A novel mixed micelles was developed to improve the solubility of Zinc phthalocyanine
(ZnPc). Sodium deoxycholate (SDC) and D-alpha tocopheryl polyethylene glycol succinate …

Molecular imaging using radiolabeled Tyrosine Kinase Inhibitors (TKI) is a promising
strategy for detection and staging of EGFR-positive cancers. A novel analogue of one such …

In this study, we demonstrate a novel H2O2 activatable photosensitizer (compound 7) which
contains a diiodo distyryl boron dipyrromethene (BODIPY) core and an arylboronate group …

Photodynamic therapy (PDT) presents a promising avenue in cancer treatment. Erlotinib, an
FDA-approved anticancer drug targeting epidermal growth factor receptor (EGFR), has …

In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

Since the discovery of photodynamic therapy, scientists have constantly been searching for
more effective and ideal photosensitizers (PSs). As part of our ongoing interest in the …

Photodynamic therapy (PDT) utilizing light-induced singlet oxygen has achieved attractive
results in anticancer fields; however, its development is hindered by limited light penetration …

A novel multifunctional nano-system, ZnPc-UCNPs-PEG-G, was designed for targeted and
in-depth photodynamic therapy. The nano-system was built via covalent conjugation, in …

Small‐molecular‐target‐based photodynamic therapy—a promising targeted anticancer
strategy—was developed by conjugating zinc (II) phthalocyanine with a small‐molecular …

Two novel glucosylated zinc (II) phthalocyanines 7a–7b, as well as the acetyl-protected
counterparts 6a–6b, have been synthesized by the Cu (I)-catalyzed 1, 3-dipolar …